Skip to main content

Table 2 Clinical characteristics of individual TN patients

From: The thalamus in trigeminal neuralgia: structural and metabolic abnormalities, and influence on surgical response

 

Sex

Age (years)

Side

Duration (years)

Pre-op VAS (mm)

Branch

NVC score

SX types

# prev

SX

Medications

Responders:

1

M

57.5

R

6

66

3

2

MVD

0

carbamazepine

2

M

49.0

R

1

100

1/2/3

2

BC

3

oxcarbazepine, baclofen

3

M

45.1

L

9

98

1

2

MVD

0

carbamazepine, pregabalin

4

F

58.5

R

11

100

2/3

3

MVD

0

carbamazepine

5

M

63.9

R

8

82

1/2/3

2

MVD

0

carbamazepine

6

M

67.5

R

6

71

2/3

1

BC

1

carbamazepine

7

F

74.1

L

3

81

2

3

MVD

0

oxcarbazepine, pregabalin

8

F

65

R

1

93

3

1

MVD

0

gabapentin

9

F

60.3

L

6

36

2/3

3

MVD

1

gabapentin, amitriptyline

10

F

64.9

L

7

100

2/3

3

MVD

0

carbamazepine, gabapentin

11

F

60.4

L

7

86

2/3

2

MVD

0

carbamazepine, oxcarbazepine

12

F

60.4

R

15

80

2/3

0

BC

0

carbamazepine

13

M

41.8

R

2

89

1/2

2

MVD

0

carbamazepine, gabapentin, topiramate

14

F

68.5

L

1

100

3

1

MVD

0

carbamazepine

15

M

61.5

R

2.5

79

3

0

MVD/IN

0

carbamazepine

16

M

63.3

R

2.5

95

2/3

3

MVD

0

oxcarbazepine, lamotrigine, gabapentin

17

M

40.6

R

1

15

2/3

0

BC

0

carbamazepine, baclofen, duloxetine, cannabis oil

Non-Responders:

18

F

37.3

L

6

63

2/3

0

MVD/IN

0

oxcarbazepine, baclofen

19

F

48.9

L

8

2

1/2/3

2

MVD

0

carbamazepine, gabapentin, baclofen

20

F

56.2

R

13

60

1/2/3

2

BC

1

carbamazepine, gabapentin, lamotrigine, baclofen, hydromorphone

21

F

55.5

R

3

100

1/2/3

0

BC

0

oxcarbazepine, gabapentin

22

F

57.5

R

13

100

1/2/3

0

BC

2

carbamazepine, gabapentin

23

F

36.3

R

3

89

2/3

3

MVD

0

carbamazepine, gabapentin, baclofen, amitriptyline, cannabis oil

  1. M male; F female; VAS visual analogue scale; Branch affected trigeminal nerve branches; NVC neurovascular compression; SX surgical treatment; MVD microvascular decompression; BC balloon compression rhizotomy; IN internal neurolysis